JAN 10, 2022 3:00 AM PST

Race May Impact Radiation Efficacy in Prostate Cancer Patients

WRITTEN BY: Katie Kokolus

Racial disparities exist between Black and White populations in many types of cancer.  Researchers actively investigate disparities in the incidence and mortality rates of different cancers.  In fact, many agencies supporting cancer research place a great deal of emphasis on funding projects that develop therapeutic approaches to reduce these racial disparities.

Compared to White men, Black men are more likely to be diagnosed with and die from prostate cancer, but little is known about how race impacts the response to prostate cancer treatment. While some of these differences are attributed to socioeconomic factors, evidence suggests that biological differences also play a role in the racial disparities associated with prostate cancer.  

A new study published in JAMA Network Open investigated the impact of radiotherapy on prostate cancer outcomes in Black and White men. The researchers used data from clinical trials conducted over twenty years, selecting reports that administered radiotherapy to prostate cancer patients and enrolled many Black men.  

The pooled analysis included data from seven published clinical trials which covered 8814 men (18.5% Black and 81.5% White) who, on average, were about 70 years old.  The author indicated that Black men were more likely to have high-risk clinical characteristics such as elevated prostate-specific antigen (PSA) levels and Gleason scores, a measurement of how different prostate cancer cells look from healthy cells.  These findings were in line with previous reports.

The study also demonstrated results that the authors referred to as “novel and unexpected”.  These included the finding that Black men were less likely than White men to experience biochemical recurrence (BCR), a rise in PSA levels following radiotherapy.  Metastasis, the spread of cancer to a distant site, was less frequent in Black men than White men.  Prostate cancer-specific mortality was also less likely in Black than White men. 

The authors noted some limitations to their study, including that race was self-reported and thus, may not capture a complete picture of biological differences among clinical trial participants. Additionally, while the initial radiotherapy treatment was standardized across trials, participants may have had follow-up treatments after the clinical trials that may have affected the long-term outcomes investigated.  

Based on reduced recurrence, metastasis, and mortality, the authors conclude that, although Black men present with more advanced prostate cancer, they are likely to be more responsive to radiotherapy than White men. The authors also discuss the idea that their results “provide high-level evidence to question the belief that prostate cancer among Black men necessarily portends a worse prognosis compared with White men.”

 

Sources: CA, Prostate Cancer and Prostatic Diseases, European Urology, JAMA Network Open

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
DEC 27, 2021
Cancer
Improving Immunotherapy with a Novel Nanoparticle
DEC 27, 2021
Improving Immunotherapy with a Novel Nanoparticle
Malignant pleural effusion (MPE) occurs in cancer patients experiencing a buildup of fluid and tumor cells in the pleura ...
JAN 07, 2022
Drug Discovery & Development
The genetic testing company 23andMe begins phase 1 clinical trial for cancer drug
JAN 07, 2022
The genetic testing company 23andMe begins phase 1 clinical trial for cancer drug
This week, 23andMe, the consumer genetic testing giant, announced that it has begun a phase 1 clinical trial o ...
FEB 08, 2022
Health & Medicine
Meet the Terpene Humulene
FEB 08, 2022
Meet the Terpene Humulene
Although the more dominant and well-known terpenes like limonene and myrcene receive more research attention, several pa ...
MAR 07, 2022
Cancer
The Value of Art Therapy for Cancer Survivors
MAR 07, 2022
The Value of Art Therapy for Cancer Survivors
Art therapy is an emerging field of medicine concentrating on improving mental health by enriching a patient’ ...
MAR 10, 2022
Drug Discovery & Development
Drug Equipped with Iron Sensor Halts Cancer Tumor Growth
MAR 10, 2022
Drug Equipped with Iron Sensor Halts Cancer Tumor Growth
A modified version of an FDA-approved drug can halt tumor growth driven by mutations in the RAS gene, which are notoriou ...
MAR 16, 2022
Cell & Molecular Biology
Remember Memorizing the Krebs Cycle? An Alternate Version Was Just Discovered
MAR 16, 2022
Remember Memorizing the Krebs Cycle? An Alternate Version Was Just Discovered
If you took biochemistry classes, chances are good you remember memorizing the Krebs cycle, a well-known metabolic pathw ...
Loading Comments...